Cineline India Reports Nil Deviation in Preferential Issue Fund Utilization
Cineline India Ltd · Others (Uncategorized) · 02 Nov 2026, 10:34 pm
Cineline India Reports Nil Deviation in Preferential Issue Fund Utilization Cineline India Limited reported zero deviation or variation in the utilization of funds raised via preferential convertible warrants for the quarter ended 30th Sep'26. Out of the total ₹4,499.99 Lakhs allocated for business growth, working capital, and general corporate purposes, the company has utilized ₹3,832.96 Lakhs. Additionally, ₹33.75 Cr was realized upon the conversion of 38,46,153 warrants into equity shares of face value ₹5 each at an issue price of ₹117 per share following the receipt of the 75% balance exercise price.
Original exchange filing (PDF)
More announcements from Cineline India Ltd
- Investor Release dated 02nd November, 2026 titled "Q2 & H1 F27 BUSINESS & FINANCIAL PERFORMANCE" · 03 Nov 2026
- Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015, please find attached Investor Presentation issued by Company for Q2FY27 · 03 Nov 2026
- Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 - Approval of Employee Stock Option Plan. · 02 Nov 2026
- Outcome of Board Meeting held today i.e. November 02, 2026. · 02 Nov 2026
- Statement of Un-Audited Financial Results for the quarter and half year ended September 30, 2026. · 02 Nov 2026
- Cineline India Limited has submitted to the Exchange, the financial results for the quarter and half year ended September 30, 2026. · 02 Nov 2026
- To consider and approve the financial results for the period ended September 30, 2026 · 02 Nov 2026
- CINELINE INDIA LIMITED has informed the Exchange about Board Meeting to be held on 02-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 . · 02 Nov 2026
